Caitong International Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04K Buy
345
+200
+138% +$2.64K ﹤0.01% 1289
2026
Q1
$2K Buy
145
+65
+81% +$980 ﹤0.01% 1241
2025
Q4
$1.44K Buy
80
+61
+321% +$1.09K ﹤0.01% 1342
2025
Q3
$352 Sell
19
-234
-92% -$3.68K ﹤0.01% 1597
2025
Q2
$4.05K Buy
+253
New +$4.51K ﹤0.01% 1104

Other funds holding CLBT

Caitong International Asset Management's CLBT Position: Q2 2026 in Review

Caitong International Asset Management increased its Cellebrite (CLBT) stake by 138% in Q2 2026, buying an estimated $2.64K and bringing the position to 345 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Caitong International Asset Management first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Caitong International Asset Management held 345 shares of Cellebrite worth $5.04K as of Q2 2026.
  • Caitong International Asset Management bought 200 Cellebrite shares in Q2 2026, an estimated $2.64K.
  • Cellebrite made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1289 holding.
  • Caitong International Asset Management first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.